Actively Recruiting
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
Led by Masonic Cancer Center, University of Minnesota · Updated on 2026-01-13
38
Participants Needed
1
Research Sites
210 weeks
Total Duration
On this page
Sponsors
M
Masonic Cancer Center, University of Minnesota
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This clinical trial evaluates the use of a tool kit, Stress, Affect, Language and Speech Analysis (SALSA), for early identification of cognitive side effects of immunotherapy compared to the standard of care assessment.
CONDITIONS
Official Title
Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older at therapy start
- Planning to receive inpatient CAR-T therapy for a primary cancer
- Fluent in English, either written or spoken
You will not qualify if you...
- Speech or hearing issues preventing assessment with SALSA
- Diagnosed cognitive impairment before CAR-T therapy
- Unwilling or unable to provide written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Minnesota/Masonic Cancer Center
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here